In this study, the case of a healthy pediatric patient who presented with herpes zoster (HZ) stromal keratitis after vaccination with live attenuated varicella vaccine (Varivax) and subsequent booster is described.


 She had received the original Varivax vaccine at 1 year of age and a booster 1 year before presentation. 
Varivax
In this study, the case of a healthy pediatric patient who presented with herpes zoster (HZ) stromal keratitis after vaccination with live attenuated varicella vaccine (Varivax) and subsequent booster is described.


 She had received the original Varivax vaccine at 1 year of age and a booster 1 year before presentation. 
Varivax
In this study, the case of a healthy pediatric patient who presented with herpes zoster (HZ) stromal keratitis after vaccination with live attenuated varicella vaccine (Varivax) and subsequent booster is described.


 She had received the original Varivax vaccine at 1 year of age and a booster 1 year before presentation. 
Varivax
In this study, the case of a healthy pediatric patient who presented with herpes zoster (HZ) stromal keratitis after vaccination with live attenuated varicella vaccine (Varivax) and subsequent booster is described.


 She had received the original Varivax vaccine at 1 year of age and a booster 1 year before presentation. 
Varivax